Latest On Chimerix, Inc (CMRX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-22 20:20 EST | News | Chimerix a buy at Baird on late-stage glioma candidate | N/A |  |
| 2023-05-07 02:21 EST | News | Chimerix, Inc. (CMRX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-04 10:40 EST | News | Chimerix GAAP EPS of -$0.24 in-line, revenue of $0.28M beats by $0.15M | N/A | |
| 2023-03-10 21:47 EST | News | Chimerix says exposure to any SVB liquidity risk is “immaterial” | N/A | |
| 2023-03-06 12:32 EST | News | Chimerix: Gaining Traction, Cash Runway To 2027 | N/A | |
| 2023-03-02 14:55 EST | News | Chimerix GAAP EPS of -$0.24 in-line, revenue of $0.8M beats by $0.22M | N/A | |
| 2023-03-02 14:55 EST | News | Chimerix, Inc. (CMRX) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-02 00:27 EST | News | Chimerix Q4 2022 Earnings Preview | N/A | |
| 2022-12-08 23:43 EST | News | Chimerix cuts workforce by 25% to focus on oncology pipeline | N/A | |
| 2022-11-14 07:09 EST | News | Chimerix: Big Doings At A Small Biotech | N/A | |
| 2022-11-11 08:04 EST | News | Chimerix rejects calls for liquidation from Rubric Capital Management | N/A | |
| 2022-11-05 10:21 EST | News | Chimerix, Inc. (CMRX) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-04 01:06 EST | News | Chimerix GAAP EPS of $2.75 beats by $0.65, revenue of $32.56M | N/A | |
| 2022-11-04 01:06 EST | News | Chimerix gains on regulatory updates for cancer therapy | N/A | |
| 2022-11-02 15:26 EST | News | Chimerix Q3 2022 Earnings Preview | N/A | |
| 2022-08-30 02:55 EST | News | Chimerix gains 20% on $551M U.S. contract for smallpox therapy | N/A | |
| 2022-08-24 02:22 EST | News | Chimerix: Advancement For Rare Brain Cancer Drug Targeting Specific Mutation | N/A | |
| 2022-08-24 02:22 EST | News | Chimerix: A Confusing Business Strategy Makes It Unconvincing | N/A | |
| 2022-08-09 00:34 EST | News | Chimerix GAAP EPS of -$0.27 misses by $0.03, revenue of $0.44M beats by $0.41M | N/A | |
| 2022-08-09 00:34 EST | News | Chimerix, Inc's (CMRX) CEO Mike Sherman on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-06 07:48 EST | News | Chimerix Q2 2022 Earnings Preview | N/A | |
| 2022-07-27 17:39 EST | News | Monkeypox cases surpass 19K worldwide as WHO urges reducing sexual partners | N/A | |
| 2022-07-27 17:39 EST | News | States to begin sharing data about monkeypox as CDC aims to better understand spread | N/A | |
| 2022-07-27 03:56 EST | News | Feds may need $7B to adequately respond to monkeypox outbreak - WaPo | N/A | |
| 2022-07-20 20:17 EST | News | WHO set for second monkeypox meeting as cases soar to more than 14K - Reuters | N/A | |
| 2022-07-16 17:59 EST | News | U.S. orders 2.5M more Bavarian Nordic monkeypox vaccine doses | N/A | |
| 2022-06-24 23:50 EST | News | Chimerix ticks higher on new order for smallpox therapy | N/A | |
| 2022-06-23 10:29 EST | News | Chimerix receives $9.3M international procurement agreement for monkeypox treatment | N/A | |
| 2022-06-06 18:52 EST | News | Chimerix: Down But Not Out | N/A | |
| 2022-05-17 05:03 EST | News | Chimerix, Inc. (CMRX) CEO Mike Sherman on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-16 10:19 EST | News | Chimerix GAAP EPS of -$0.28 beats by $0.07, revenue of $0.02M beats by $0.02M | N/A | |
| 2022-05-16 10:19 EST | News | Chimerix stock slumps ~37% on Emergent acquiring rights to smallpox therapy Tembexa | N/A | |
| 2022-04-14 06:20 EST | News | Chimerix says unusual trading may be due to smallpox antiviral development with HHS | N/A | |
| 2022-03-01 23:06 EST | News | Chimerix GAAP EPS of -$0.45 misses by $0.28, revenue of $0.05M misses by $18.01M | N/A | |
| 2022-03-01 23:06 EST | News | Chimerix, Inc. (CMRX) CEO Mike Sherman on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-01 04:47 EST | News | Chimerix Q4 2021 Earnings Preview | N/A | |
| 2022-01-18 19:15 EST | News | Chimerix announces publication of study data for the cancer candidate | N/A | |
| 2022-01-05 03:02 EST | News | Chimerix: Searching For Clarity | N/A | |
| 2021-11-30 23:04 EST | News | Chimerix rises after announcing govt. interest in purchasing smallpox drug | N/A | |
| 2021-11-19 09:50 EST | News | Chimerix announces positive ONC201 data in brain cancer | N/A | |
| 2021-11-09 06:17 EST | News | Chimerix recovers from last week's post-Q3 earnings plunge | N/A | |
| 2021-11-06 18:24 EST | News | Chimerix, Inc. (CMRX) CEO Mike Sherman on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-05 03:36 EST | News | Chimerix EPS in-line, misses on revenue | N/A | |
| 2021-11-05 03:36 EST | News | Chimerix shares slide 27% after Q3 topline miss, cash position update | N/A | |
| 2021-11-03 10:17 EST | News | Chimerix Q3 2021 Earnings Preview | N/A | |
| 2021-10-12 22:39 EST | News | Warning: CMRX is at high risk of performing badly | N/A | |
| 2021-10-07 07:26 EST | News | CMRX is at high risk of performing badly | N/A | |
| 2021-09-17 16:53 EST | News | Warning: CMRX has been downgraded to Very Bearish. | N/A | |
| 2021-08-14 07:51 EST | News | Chimerix, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-08 10:19 EST | News | Chimerix, Inc. (CMRX) CEO Mike Sherman on Q2 2021 Results - Earnings Call Transcript | N/A | |
About Chimerix, Inc (CMRX):
Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include brincidofovir (BCV), an antiviral drug candidate in development as a medical countermeasure for smallpox; dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy; and ONC201 a program for potentially treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.
General
- Name Chimerix, Inc
- Symbol CMRX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 54
- Fiscal Year EndDecember
- IPO Date2013-04-11
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.chimerix.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 115.76
- Price/Book (Most Recent Quarter) 11.68
- Enterprise Value Revenue 145.32
- Enterprise Value EBITDA 0.23
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.80
- Next Year EPS Estimate -$0.39
- Next Quarter EPS Estimate -$0.76
- Operating Margin -829%
- Return on Assets -27%
- Return on Equity -47%
- Revenue 5.37 million
- Earnings Per Share -$1.32
- Revenue Per Share $0.09
- Gross Profit -30860000
- Quarterly Earnings Growth -83.4%
View More
Highlights
- Market Capitalization 819.09 million
- EBITDA -68996000
- PE Ratio -1.01
- Analyst Target Price $13.33
- Book Value Per Share $1.17
View More
Share Statistics
- Shares Outstanding 85.68 million
- Shares Float 74.24 million
- % Held by Insiders 1834%
- % Held by Institutions 53.07%
- Shares Short 975040
- Shares Short Prior Month 794294
- Short Ratio 1.32
- Short % of Float 1%
- Short % of Shares Outstanding 1%
View More
Technicals
- Beta 1.66
- 52 Week High $11.57
- 52 Week Low $1.28
- 50 Day Moving Average 9.88
- 200 Day Moving Average 5.53
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Chimerix, Inc (CMRX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Chimerix, Inc (CMRX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | -$0.19 | -$0.19 | 0% |
| 2020-09-30 | 2020-11-05 | $1.61 million | -$0.18 | -$0.17 | -9.09% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.16 | -$0.18 | 8.57% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.17 | -$0.15 | -13.33% |
| 2019-12-31 | 2020-02-25 | $6.77 million | -$0.06 | -$0.17 | 64.71% |
| 2019-09-30 | 2019-11-05 | $1.96 million | -$1.26 | -$0.22 | -486.05% |
| 2019-06-30 | 2019-08-08 | $1.44 million | -$0.35 | -$0.37 | 4.11% |
| 2019-03-31 | 2019-05-09 | $2.36 million | -$0.35 | -$0.35 | -1.45% |
| 2018-12-31 | 2019-03-05 | $4.86 million | -$0.29 | -$0.36 | 19.44% |
| 2018-09-30 | 2018-11-08 | $369000 | -$0.33 | -$0.42 | 20.48% |
| 2018-06-30 | 2018-08-08 | $1.19 million | -$0.39 | -$0.44 | 11.66% |
| 2018-03-31 | 2018-05-07 | $790000 | -$0.42 | -$0.43 | 1.75% |
| 2017-12-31 | 2018-03-01 | $644000 | -$0.41 | -$0.48 | 13.78% |
| 2017-09-30 | 2017-11-08 | $897000 | -$0.37 | -$0.43 | 13.37% |
| 2017-06-30 | 2017-08-07 | $675000 | -$0.36 | -$0.41 | 11.57% |
| 2017-03-31 | 2017-05-09 | $1.08 million | -$0.38 | -$0.36 | -4.28% |
| 2016-12-31 | 2017-03-02 | $1.98 million | -$0.32 | -$0.39 | 17.12% |
| 2016-09-30 | 2016-11-07 | $653000 | -$0.37 | -$0.40 | 7.57% |
| 2016-06-30 | 2016-08-08 | $1.84 million | -$0.39 | -$0.51 | 24.08% |
| 2016-03-31 | 2016-05-09 | $1.23 million | -$0.57 | -$0.70 | 18.15% |
| 2015-12-31 | 2016-02-29 | $3.11 million | -$0.82 | -$0.73 | -12.22% |
| 2015-09-30 | 2015-11-05 | $2.27 million | -$0.70 | -$0.59 | -18.64% |
| 2015-06-30 | 2015-08-06 | $4.14 million | -$0.59 | -$0.58 | -1.72% |
| 2015-03-31 | 2015-05-11 | $1.24 million | -$0.54 | -$0.57 | 5.26% |
| 2014-12-31 | 2015-03-06 | $1.16 million | -$0.52 | -$0.48 | -8.33% |
| 2014-09-30 | 2014-11-07 | $1.19 million | -$0.47 | -$0.40 | -17.5% |
| 2014-06-30 | 2014-08-07 | $919000 | -$0.39 | -$0.44 | 11.36% |
| 2014-03-31 | 2014-05-09 | $780000 | -$0.39 | -$0.36 | -8.33% |
| 2013-12-31 | 2014-03-07 | $879000 | -$0.31 | -$0.41 | 24.39% |
| 2013-09-30 | 2013-11-14 | $912000 | -$0.26 | -$0.38 | 31.58% |
| 2013-06-30 | 2013-08-14 | $808000 | -$0.91 | -$0.40 | -127.5% |
| 2013-03-31 | 2013-05-13 | $1.77 million | -$22.58 | -$2.43 | -829.22% |
Chimerix, Inc (CMRX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 8.69 million | 10.02 million | N/A | N/A | N/A |
| Income Before Tax | -11.68 million | -11.41 million | N/A | N/A | -3.5 million |
| Selling General Administrative | 4.19 million | 3.15 million | N/A | N/A | 3.15 million |
| Gross Profit | N/A | N/A | N/A | N/A | -726000 |
| Ebit | -11.76 million | -11.47 million | N/A | N/A | -3.87 million |
| Operating Income | -11.76 million | -11.56 million | N/A | N/A | -3.87 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | 1.61 million | N/A | N/A | 6.77 million |
| Cost of Revenue | N/A | N/A | N/A | N/A | 7.49 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | 370000 |
| Net Income From Continuing Operations | -11.68 million | -11.41 million | N/A | N/A | -3.5 million |
| Net Income Applicable to Common Shares | -11.68 million | -11.41 million | -10.02 million | -10.42 million | -3.5 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -7.33 million | 36.24 million | N/A | N/A | 39.7 million |
| Change to Liabilities | 1.28 million | N/A | -2.54 million | N/A | -3.36 million |
| Total Cash Flow from Investing Activities | -7.33 million | N/A | 18.24 million | N/A | 39.7 million |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | 260000 | 578000 | N/A | N/A | 166000 |
| Change to Operating Activities | 475000 | N/A | 762000 | N/A | -221000 |
| Change in Cash | -15.37 million | 28.95 million | N/A | N/A | -2.3 million |
| Total Cash from Operating Activities | -8.3 million | -7.87 million | -10.82 million | N/A | -42.16 million |
| Depreciation | 93000 | 104000 | N/A | N/A | 145000 |
| Other Cash Flow from Investing Activities | 10000 | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | -11000 | 712000 | N/A | N/A | -1.05 million |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 1.28 million | N/A | 1.11 million | N/A | 36.06 million |
| Capital Expenditures | 49000 | 4000 | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 11.35 million | 10.34 million | N/A | N/A | 9.42 million |
| Total Stockholder Equity | 73.38 million | 83.17 million | N/A | N/A | 109.95 million |
| Other Current Liabilities | N/A | 2.92 million | N/A | N/A | N/A |
| Total Assets | 84.72 million | 93.5 million | N/A | N/A | 119.38 million |
| Common Stock | 63000 | 63000 | 62000 | 62000 | 62000 |
| Other Current Assets | 2.36 million | 89.87 million | N/A | N/A | N/A |
| Retained Earnings | -712.36 million | -700.69 million | -689.27 million | -679.26 million | -668.84 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | 27000 | 26000 | 16000 | 34000 |
| Cash | 46.99 million | N/A | N/A | N/A | 16.9 million |
| Total Current Liabilities | 8.53 million | 7.41 million | N/A | N/A | 9.23 million |
| Other Stockholder Equity | N/A | 33000 | 130000 | -11000 | 35000 |
| Property, Plant & Equipment | 214000 | 3.23 million | 2.75 million | 1.01 million | 1.25 million |
| Total Current Assets | 81.66 million | 90.24 million | N/A | N/A | 118.09 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 73.38 million | 83.17 million | 93.14 million | 101.04 million | 109.95 million |
| Short Term Investments | 31.97 million | N/A | N/A | N/A | 96.57 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 8.53 million | 880000 | N/A | N/A | 2.4 million |
Chimerix, Inc (CMRX) Chart:
Chimerix, Inc (CMRX) News:
Below you will find a list of latest news for Chimerix, Inc (CMRX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Chimerix, Inc (CMRX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 1 | 0.05 | CALL | 0 | 263 | 97.7 | FALSE | 0 | 0 |
| 2024-05-17 | 2 | 0.05 | CALL | 0 | 28 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 3 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1 | 0.15 | PUT | 1 | 457 | 108.4 | TRUE | 0.15 | 0 |
| 2024-05-17 | 2 | 0.85 | PUT | 0 | 2 | 410.49 | TRUE | 0 | 0 |
| 2024-05-17 | 3 | 0 | PUT | 0 | 0 | 1033.24 | TRUE | 0 | 0 |
| 2024-05-17 | 4 | 0 | PUT | 0 | 0 | 467.95 | TRUE | 0 | 0 |
| 2024-06-21 | 1 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 3 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 1 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 2 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 3 | 0 | PUT | 0 | 0 | 484.46 | TRUE | 0 | 0 |
| 2024-06-21 | 4 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 1 | 0.1 | CALL | 0 | 52 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2 | 0.14 | CALL | 0 | 61 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 3 | 0.1 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 4 | 0.05 | CALL | 0 | 61 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 1 | 0.15 | PUT | 0 | 380 | 43.94 | TRUE | 0 | 0 |
| 2024-08-16 | 2 | 0 | PUT | 0 | 0 | 130.81 | TRUE | 0 | 0 |
| 2024-08-16 | 3 | 0 | PUT | 0 | 0 | 310.04 | TRUE | 0 | 0 |
| 2024-08-16 | 4 | 0 | PUT | 0 | 0 | 444.83 | TRUE | 0 | 0 |
| 2024-11-15 | 1 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 2 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 3 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 1 | 0.2 | PUT | 0 | 190 | 71.1 | TRUE | 0 | 0 |
| 2024-11-15 | 2 | 0 | PUT | 0 | 0 | 103.97 | TRUE | 0 | 0 |
| 2024-11-15 | 3 | 0 | PUT | 0 | 0 | 136.94 | TRUE | 0 | 0 |
| 2024-11-15 | 4 | 0 | PUT | 0 | 0 | 470.43 | TRUE | 0 | 0 |
| 2025-01-17 | 0.5 | 0.5 | CALL | 0 | 6 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 1 | 0.29 | CALL | 0 | 567 | 82.54 | FALSE | 0 | 0 |
| 2025-01-17 | 1.5 | 0.15 | CALL | 4 | 1304 | 88.06 | FALSE | 0.15 | 0 |
| 2025-01-17 | 2 | 0.1 | CALL | 0 | 396 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 2.5 | 0.09 | CALL | 0 | 765 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 3 | 0.1 | CALL | 0 | 9 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 3.5 | 0.1 | CALL | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 4 | 0.05 | CALL | 0 | 20 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 4.5 | 0.05 | CALL | 0 | 30 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 0.5 | 0.1 | PUT | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 1 | 0.25 | PUT | 0 | 117 | 71.74 | TRUE | 0 | 0 |
| 2025-01-17 | 1.5 | 0 | PUT | 0 | 0 | 80.1 | TRUE | 0 | 0 |
| 2025-01-17 | 2 | 1 | PUT | 0 | 20 | 136.56 | TRUE | 0 | 0 |
| 2025-01-17 | 2.5 | 0 | PUT | 0 | 0 | 218.92 | TRUE | 0 | 0 |
| 2025-01-17 | 3 | 1.9 | PUT | 0 | 0 | 124.44 | TRUE | 0 | 0 |
| 2025-01-17 | 3.5 | 2.3 | PUT | 0 | 0 | 245.05 | TRUE | 0 | 0 |
| 2025-01-17 | 4 | 0 | PUT | 0 | 0 | 359.95 | TRUE | 0 | 0 |
| 2025-01-17 | 4.5 | 3.3 | PUT | 0 | 0 | 282.43 | TRUE | 0 | 0 |
Latest CMRX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $1.445 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.445 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.445 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.445 |
| Jun 13, 2022 7:59 PM EST | 300 | $1.445 |
Chimerix, Inc (CMRX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120038385/0001209191-20-038385-index.htm |
| 2020-08-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1117480/000000000020007418/0000000000-20-007418-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000021545719003216/0000215457-19-003216-index.htm |
| 2018-09-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000031506618002329/0000315066-18-002329-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000031506619000929/0000315066-19-000929-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000083423720004673/0000834237-20-004673-index.htm |
| 2019-08-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000089924319021086/0000899243-19-021086-index.htm |
| 2019-08-07 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000089924319021199/0000899243-19-021199-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000110465920021814/0001104659-20-021814-index.htm |
| 2020-08-10 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1117480/000110465920092833/0001104659-20-092833-index.htm |
| 2020-08-13 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1117480/000110465920094619/0001104659-20-094619-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748018000028/0001117480-18-000028-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1117480/000111748018000029/0001117480-18-000029-index.htm |
| 2018-09-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748018000031/0001117480-18-000031-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748018000035/0001117480-18-000035-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1117480/000111748018000036/0001117480-18-000036-index.htm |
| 2019-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000002/0001117480-19-000002-index.htm |
| 2019-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000004/0001117480-19-000004-index.htm |
| 2019-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000008/0001117480-19-000008-index.htm |
| 2019-03-05 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000010/0001117480-19-000010-index.htm |
| 2019-03-05 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000011/0001117480-19-000011-index.htm |
| 2019-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000014/0001117480-19-000014-index.htm |
| 2019-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000018/0001117480-19-000018-index.htm |
| 2019-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000019/0001117480-19-000019-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000022/0001117480-19-000022-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000023/0001117480-19-000023-index.htm |
| 2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000025/0001117480-19-000025-index.htm |
| 2019-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000027/0001117480-19-000027-index.htm |
| 2019-07-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000029/0001117480-19-000029-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000032/0001117480-19-000032-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000033/0001117480-19-000033-index.htm |
| 2019-08-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000036/0001117480-19-000036-index.htm |
| 2019-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000038/0001117480-19-000038-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000042/0001117480-19-000042-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1117480/000111748019000044/0001117480-19-000044-index.htm |
| 2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000002/0001117480-20-000002-index.htm |
| 2020-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000005/0001117480-20-000005-index.htm |
| 2020-02-25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000006/0001117480-20-000006-index.htm |
| 2020-02-25 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000008/0001117480-20-000008-index.htm |
| 2020-03-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000011/0001117480-20-000011-index.htm |
| 2020-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000013/0001117480-20-000013-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000017/0001117480-20-000017-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000018/0001117480-20-000018-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000021/0001117480-20-000021-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000022/0001117480-20-000022-index.htm |
| 2020-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000024/0001117480-20-000024-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000026/0001117480-20-000026-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000028/0001117480-20-000028-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000031/0001117480-20-000031-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1117480/000111748020000032/0001117480-20-000032-index.htm |
| 2019-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000114420419005137/0001144204-19-005137-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000114420419008069/0001144204-19-008069-index.htm |
| 2019-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000114420419013146/0001144204-19-013146-index.htm |
| 2019-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000114420419018944/0001144204-19-018944-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1117480/000114420419036752/0001144204-19-036752-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000117266119000547/0001172661-19-000547-index.htm |
| 2019-04-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000117266119001040/0001172661-19-001040-index.htm |
| 2019-12-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000117266119002407/0001172661-19-002407-index.htm |
| 2019-08-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000119312519214053/0001193125-19-214053-index.htm |
| 2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919118039004/0001209191-18-039004-index.htm |
| 2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919118039005/0001209191-18-039005-index.htm |
| 2018-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919118039006/0001209191-18-039006-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119005356/0001209191-19-005356-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119005359/0001209191-19-005359-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119005361/0001209191-19-005361-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119005994/0001209191-19-005994-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119005995/0001209191-19-005995-index.htm |
| 2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119008275/0001209191-19-008275-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119008276/0001209191-19-008276-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119008277/0001209191-19-008277-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119008279/0001209191-19-008279-index.htm |
| 2019-04-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119024155/0001209191-19-024155-index.htm |
| 2019-04-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119024159/0001209191-19-024159-index.htm |
| 2019-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119024161/0001209191-19-024161-index.htm |
| 2019-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119024163/0001209191-19-024163-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119029414/0001209191-19-029414-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119031416/0001209191-19-031416-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119031951/0001209191-19-031951-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119032129/0001209191-19-032129-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119033140/0001209191-19-033140-index.htm |
| 2019-06-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119038716/0001209191-19-038716-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119038717/0001209191-19-038717-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119038718/0001209191-19-038718-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119038719/0001209191-19-038719-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119038721/0001209191-19-038721-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119038722/0001209191-19-038722-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119038723/0001209191-19-038723-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119038725/0001209191-19-038725-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119038727/0001209191-19-038727-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119038728/0001209191-19-038728-index.htm |
| 2019-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119043295/0001209191-19-043295-index.htm |
| 2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119051063/0001209191-19-051063-index.htm |
| 2019-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119055525/0001209191-19-055525-index.htm |
| 2019-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119055615/0001209191-19-055615-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919119056337/0001209191-19-056337-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120002630/0001209191-20-002630-index.htm |
| 2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120004684/0001209191-20-004684-index.htm |
| 2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120004688/0001209191-20-004688-index.htm |
| 2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120004690/0001209191-20-004690-index.htm |
| 2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120004692/0001209191-20-004692-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120008293/0001209191-20-008293-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120008297/0001209191-20-008297-index.htm |
| 2020-02-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120012644/0001209191-20-012644-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120012650/0001209191-20-012650-index.htm |
| 2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120019132/0001209191-20-019132-index.htm |
| 2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120019140/0001209191-20-019140-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120019489/0001209191-20-019489-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120036521/0001209191-20-036521-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120036522/0001209191-20-036522-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120036523/0001209191-20-036523-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120036525/0001209191-20-036525-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120036526/0001209191-20-036526-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120036527/0001209191-20-036527-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120036529/0001209191-20-036529-index.htm |
| 2020-06-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120038383/0001209191-20-038383-index.htm |
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120038385/0001209191-20-038385-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120045424/0001209191-20-045424-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120045996/0001209191-20-045996-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120046206/0001209191-20-046206-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120047570/0001209191-20-047570-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1117480/000120919120053071/0001209191-20-053071-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000125889719000969/0001258897-19-000969-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000125889720000868/0001258897-20-000868-index.htm |
| 2020-08-21 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1117480/000149315220016518/0001493152-20-016518-index.htm |
| 2019-07-31 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1117480/000156761919015537/0001567619-19-015537-index.htm |
| 2020-08-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1117480/999999999520002176/9999999995-20-002176-index.htm |
| 2018-08-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1117480/999999999718007365/9999999997-18-007365-index.htm |
| 2019-02-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1117480/999999999719000593/9999999997-19-000593-index.htm |
| 2019-03-15 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1117480/999999999719001263/9999999997-19-001263-index.htm |
| 2019-04-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1117480/999999999719003537/9999999997-19-003537-index.htm |
| 2019-08-02 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1117480/999999999719006373/9999999997-19-006373-index.htm |
| 2019-11-08 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1117480/999999999719007507/9999999997-19-007507-index.htm |
| 2020-03-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1117480/999999999720001137/9999999997-20-001137-index.htm |
| 2020-03-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1117480/999999999720001138/9999999997-20-001138-index.htm |
| 2020-09-30 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1117480/999999999720004845/9999999997-20-004845-index.htm |
Chimerix, Inc (CMRX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chimerix, Inc (CMRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1834%Institutional Ownership: 5307%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-08-04 | MARTHA J DEMSKI | Director | Sell | 5,000.00 | 3.25 | 16,250.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120045424/0001209191-20-045424-index.htm |
| 2020-08-05 | MARTHA J DEMSKI | Director | Sell | 2,500.00 | 3.27 | 8,187.25 | 0.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120045424/0001209191-20-045424-index.htm |
| 2020-08-06 | MARTHA J DEMSKI | Director | Sell | 2,500.00 | 3.29 | 8,223.75 | 0.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120045996/0001209191-20-045996-index.htm |
| 2020-08-07 | MARTHA J DEMSKI | Director | Sell | 2,500.00 | 3.25 | 8,125.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120045996/0001209191-20-045996-index.htm |
| 2020-08-10 | MARTHA J DEMSKI | Director | Sell | 1,584.00 | 3.25 | 5,148.48 | 0.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120046206/0001209191-20-046206-index.htm |
| 2019-11-06 | Robert J. Meyer | Director | Buy | 10,000.00 | 1.58 | 15,797.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119055525/0001209191-19-055525-index.htm |
| 2019-11-06 | Michael T. Andriole | Chief Business Officer | Buy | 100,000.00 | 1.56 | 156,000.00 | 100,000.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119055615/0001209191-19-055615-index.htm |
| 2020-03-12 | Michael A. Sherman | Chief Executive Officer | Buy | 72,995.00 | 1.45 | 105,652.96 | 102,995.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120019140/0001209191-20-019140-index.htm |
| 2019-11-11 | FRED A MIDDLETON | Director | Buy | 20,000.00 | 1.66 | 33,190.00 | 117,523.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119056337/0001209191-19-056337-index.htm |
| 2020-08-19 | Robert J. Meyer | Director | Buy | 3,500.00 | 2.92 | 10,220.00 | 13,500.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120047570/0001209191-20-047570-index.htm |
| 2019-11-13 | FRED A MIDDLETON | Director | Buy | 30,000.00 | 1.82 | 54,567.00 | 147,523.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119056337/0001209191-19-056337-index.htm |
| 2020-03-16 | Michael T. Andriole | Chief Business Officer | Buy | 33,300.00 | 1.43 | 47,522.43 | 149,729.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120019489/0001209191-20-019489-index.htm |
| 2019-02-05 | Michael Albert Alrutz | Principal Executive Officer | Buy | 100,000.00 | 156,645.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119008276/0001209191-19-008276-index.htm | ||
| 2020-08-10 | MARTHA J DEMSKI | Director | Buy | 1,584.00 | 3.16 | 5,005.44 | 1,584.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120046206/0001209191-20-046206-index.htm |
| 2020-03-12 | FRED A MIDDLETON | Director | Buy | 50,000.00 | 1.40 | 69,900.00 | 197,523.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120019132/0001209191-20-019132-index.htm |
| 2019-02-05 | Timothy W. Trost | SVP, CFO & Secretary | Buy | 100,000.00 | 214,530.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119008279/0001209191-19-008279-index.htm | ||
| 2019-01-23 | Garrett Nichols | Chief Medical Officer | Buy | 125,000.00 | 215,471.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119005359/0001209191-19-005359-index.htm | ||
| 2020-08-05 | MARTHA J DEMSKI | Director | Buy | 2,500.00 | 3.16 | 7,900.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120045424/0001209191-20-045424-index.htm |
| 2020-08-06 | MARTHA J DEMSKI | Director | Buy | 2,500.00 | 3.16 | 7,900.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120045996/0001209191-20-045996-index.htm |
| 2020-08-07 | MARTHA J DEMSKI | Director | Buy | 2,500.00 | 3.16 | 7,900.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120045996/0001209191-20-045996-index.htm |
| 2020-02-10 | Garrett Nichols | Chief Medical Officer | Sell | 8,805.00 | 1.68 | 14,830.26 | 260,066.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120008297/0001209191-20-008297-index.htm |
| 2020-02-07 | Garrett Nichols | Chief Medical Officer | Sell | 2,550.00 | 1.70 | 4,335.00 | 268,871.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120008297/0001209191-20-008297-index.htm |
| 2020-01-07 | Garrett Nichols | Chief Medical Officer | Sell | 30,680.00 | 2.15 | 66,044.84 | 271,421.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120002630/0001209191-20-002630-index.htm |
| 2019-05-20 | Michael A. Sherman | Chief Executive Officer | Buy | 30,000.00 | 3.48 | 104,316.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119031416/0001209191-19-031416-index.htm |
| 2019-02-05 | Garrett Nichols | Chief Medical Officer | Buy | 100,000.00 | 312,376.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119008277/0001209191-19-008277-index.htm | ||
| 2019-05-28 | MARTHA J DEMSKI | Director | Buy | 18,000.00 | 3.60 | 64,800.00 | 37,013.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119033140/0001209191-19-033140-index.htm |
| 2020-08-04 | MARTHA J DEMSKI | Director | Buy | 5,000.00 | 3.16 | 15,800.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120045424/0001209191-20-045424-index.htm |
| 2019-09-26 | David Jakeman | Principal Accounting Officer | Buy | 56,000.00 | 76,006.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119051063/0001209191-19-051063-index.htm | ||
| 2020-10-02 | David Jakeman | Principal Accounting Officer | Sell | 4,270.00 | 2.48 | 10,589.60 | 85,117.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120053071/0001209191-20-053071-index.htm |
| 2020-02-07 | David Jakeman | Principal Accounting Officer | Sell | 2,290.00 | 1.70 | 3,893.00 | 87,876.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120008293/0001209191-20-008293-index.htm |
| 2020-01-21 | David Jakeman | Principal Accounting Officer | Buy | 14,160.00 | 90,166.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919120004684/0001209191-20-004684-index.htm | ||
| 2019-05-10 | FRED A MIDDLETON | Director | Buy | 30,000.00 | 2.92 | 87,678.00 | 97,523.00 | https://www.sec.gov/Archives/edgar/data/1117480/000120919119029414/0001209191-19-029414-index.htm |